Cross-talk between retinoic acid and stat3 signaling pathways in acute promyelocytic leukemia

Leukemia and Lymphoma

Volumn 44, Issue 12, 2003, Pages 2023-2029

  Dong, Shuo ^a,b   Chen, Sai Juan ^b   Tweardy, David J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Acute promyelocytic leukemia (APL); All trans retinoic; Retinoic acid receptor (RAR )

Indexed keywords

ALITRETINOIN; CHIMERIC PROTEIN; DNA; HYBRID PROTEIN; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; STAT1 PROTEIN; STAT2 PROTEIN; STAT3 PROTEIN; STAT4 PROTEIN; STAT5 PROTEIN; STAT5B PROTEIN; STAT6 PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; CELL DIFFERENTIATION; CHROMOSOME ABERRATION; DNA RESPONSIVE ELEMENT; DRUG RESPONSE; GENETIC TRANSCRIPTION; HUMAN; LEUKEMIA CELL; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN FUNCTION; PROTEIN INDUCTION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; DNA-BINDING PROTEINS; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MODELS, BIOLOGICAL; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, RETINOIC ACID; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRETINOIN; UP-REGULATION;

EID: 0242467307     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/1042819031000116670     Document Type: Review

References (66)

1. Chen, Z., Tong, J.H., Dong, S., Zhu, J., Wang, Z.Y. and Chen, S.J. (1996) "Retinoic acid regulatory pathways, chromosomal translocations, and acute promyelocytic leukemia", Genes Chromosomes Cancer 15, 147-156.
2. Dong, S., Geng, J.P., Tong, J.H., Wu, Y., Cai, J.R., Sun, G.L., Chen, S.R., Wang, Z.Y., Larsen, C.J., Berger, R., et al. (1993) "Breakpoint clusters of the PML gene in acute promyelocytic leukemia: primary structure of the reciprocal products of the PML-RARA gene in a patient with t(15;17)", Genes Chromosomes Cancer 6, 133-139.
3. Tong, J.H., Dong, S., Geng, J.P., Huang, W., Wang, Z.Y., Sun, G.L., Chen, S.J., Chen, Z., Larsen, C.J. and Berger, R. (1992) "Molecular rearrangements of the MYL gene in acute promyelocytic leukemia (APL, M3) define a breakpoint cluster region as well as some molecular variants", Oncogene 7, 311-316.
4. Zelent, A., Guidez, F., Melnick, A., Waxman, S. and Licht, J.D. (2001) "Translocations of the RARalpha gene in acute promyelocytic leukemia", Oncogene 20, 7186-7203.
5. Dong, S., Qiu, J., Stenoien, D.L., Brinkley, W.R., Mancini, M.A. and Tweardy, D.J. (2003) "Essential role for the dimerization domain of NuMA-RARalpha in its oncogenic activities and localization to NuMA sites within the nucleus", Oncogene 22, 858-868.
6. Dong, S. and Tweardy, D.J. (2002) "Interactions of STAT5b-RARalpha, a novel acute promyelocytic leukemia fusion protein, with retinoic acid receptor and STAT3 signaling pathways", Blood 99, 2637-2646.
7. Dong, S., Zhu, J., Reid, A., Strutt, P., Guidez, F., Zhong, H.J., Wang, Z.Y., Licht, J., Waxman, S., Chomienne, C., et al. (1996) "Aminoterminal protein-protein interaction motif (POZ-domain) is responsible for activities of the promyelocytic leukemia zinc finger-retinoic acid receptor-alpha fusion protein", Proc. Natl Acad. Sci. USA 93, 3624-3629.
8. Melnick, A. and Licht, J.D. (1999) "Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia", Blood 93, 3167-3215.
9. Chambon, P. (1995) "The molecular and genetic dissection of the retinoid signaling pathway", Recent Prog. Horm. Res. 50, 317-332.
10. Chambon, P. (1994) "The retinoid signaling pathway: molecular and genetic analyses", Semin. Cell Biol. 5, 115-125.
11. Chambon, P. (1996) "A decade of molecular biology of retinoic acid receptors", FASEB J. 10, 940-954.
12. Chen, J.D. and Li, H. (1998) "Coactivation and corepression in transcriptional regulation by steroid/nuclear hormone receptors", Crit. Rev. Eukaryot. Gene. Expr. 8, 169-190.
13. Collins, S.J. (2002) "The role of retinoids and retinoic acid receptors in normal hematopoiesis", Leukemia 16, 1896-1905.
14. Lin, R.J. and Evans, R.M. (2000) "Acquisition of oncogenic potential by RAR chimeras in acute promyelocytic leukemia through formation of homodimers", Mol. Cell 5, 821-830.
15. Lin, R.J., Nagy, L., Inoue, S., Shao, W., Miller, W.H., Jr and Evans, R.M. (1998) "Role of the histone deacetylase complex in acute promyelocytic leukaemia", Nature 391, 811-814.
16. Breitman, T.R., Selonick, S.E. and Collins, S.J. (1980) "Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid", Proc. Natl Acad. Sci. USA 77, 2936-2940.
17. Huang, M.E., Ye, Y.C., Chen, S.R., Chai, J.R., Lu, J.X., Zhoa, L., Gu, L.J. and Wang, Z.Y. (1988) "Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia", Blood 72, 567-572.
18. Degos, L. and Wang, Z.Y. (2001) "All trans retinoic acid in acute promyelocytic leukemia", Oncogene 20, 7140-7145.
19. Darnell, J.E. (1997) "STATs and gene regulation", Science 277, 1630-1635.
20. Brombreg, J. and Darnell, J.E., Jr (2000) "The role of STATs in transcriptional control and their impact on cellular function", Oncogene 19, 2468-2473.
21. Akira, S. (1997) "IL-6-regulated transcription factors", Int. J. Biochem. Cell Biol. 29, 1401-1418.
22. Zhong, Z., Wen, Z. and Darnell, Jr., J.E. (1994) "STAT3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6", Science 264, 95-98.
23. Wen, Z., Zhong, Z. and Darnell, J.E., Jr (1995) "Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation", Cell 82, 241-250.
24. Schindler, C. and Darnell, J.E., Jr (1995) "Transcriptional responses to polypeptide ligands: the JAK-STAT pathway", Annu. Rev. Biochem. 64, 621-651.
25. Fukada, T., Ohtani, T., Yoshida, Y., Shirogane, T., Nishida, K., Nakajima, K., Hibi, M. and Hirano, T. (1998) "STAT3 orchestrates contradictory signals in cytokine-induced G1 to S cell-cycle transition", EMBO J. 17, 6670-6677.
26. Fukada, T., Hibi, M., Yamanaka, Y., Takahashi-Tezuka, M., Fujitani, Y., Yamaguchi, T., Nakajima, K. and Hirano, T. (1996) "Two signals are necessary for cell proliferation induced by a cytokine receptor gp 130: involvement of STAT3 in anti-apoptosis", Immunity 5, 449-460.
27. Shirogane, T., Fukada, T., Muller, J.M., Shima, D.T., Hibi, M. and Hirano, T. (1999) "Synergistic roles for Pim-1 and c-Myc in STAT3-mediated cell cycle progression and antiapoptosis", Immunity 11, 709-719.
28. Boeuf, H., Hauss, C., Graeve, F.D., Baran, N. and Kedinger, C. (1997) "Leukemia inhibitory factor-dependent transcriptional activation in embryonic stem cells", J. Cell. Biol. 138, 1207-1217.
29. Shimozaki, K., Nakajima, K., Hirano, T. and Nagata, S. (1997) "Involvement of STAT3 in the granulocyte colony-stimulating factor-induced differentiation of myeloid cells", J. Biol. Chem. 272, 25184-25189.
30. de Koning, J.P., Soede-Bobok, A.A., Ward, A.C., Schelen, A.M., Antonissen, C., van Leeuwen, D., Lowenberg, B. and Touw, I.P. (2000) "STAT3-mediated differentiation and survival and of myeloid cells in response to granulocyte colony-stimulating factor: role for the cyclin-dependent kinase inhibitor p27(Kip1)", Oncogene 19, 3290-3298.
31. Chakraborty, A. and Tweardy, D.J. (1998) "STAT3 and G-CSF-induced myeloid differentiation", Leuk. Lymphoma 30, 433-442.
32. Chakraborty, A. and Tweardy, D.J. (1998) "Granulocyte colony-stimulating factor activates a 72-kDa isoform of STAT3 in human neutrophils", J. Leukoc. Biol. 64, 675-680.
33. Takeda, K., Noguchi, K., Shi, W., Tanaka, T., Matsumoto, M., Yoshida, N., Kishimoto, T. and Akira, S. (1997) "Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality", Proc. Natl Acad. Sci. USA 94, 3801-3804.
34. Akira, S. (2000) "Roles of STAT3 defined by tissue-specific gene targeting", Oncogene 19, 2607-2611.
35. Takeda, T., Kurachi, H., Yamamoto, T., Nishio, Y., Nakatsuji, Y., Morishige, K., Miyake, A. and Murata, Y. (1998) "Crosstalk between the interleukin-6 (IL-6)-JAK-STAT and the glucocorticoid-nuclear receptor pathway: synergistic activation of IL-6 response element by IL-6 and glucocorticoid", J. Endocrinol. 159, 323-330.
36. Takeda, K., Clausen, B.E., Kaisho, T., Tsujimura, T., Terada, N., Forster, I. and Akira, S. (1999) "Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils", Immunity 10, 39-49.
37. Sano, S., Itami, S., Takeda, K., Tarutani, M., Yamaguchi, Y., Miura, H., Yoshikawa, K., Akira, S. and Takeda, J. (1999) "Keratinocyte-specific ablation of Stat3 exhibits impaired skin remodeling, but does not affect skin morphogenesis", EMBO J. 18, 4657-4668.
38. Chapman, R.S., Lourenco, P.C., Tonner, E., Flint, D.J., Selbert, S., Takeda, K., Akira, S., Clarke, A.R. and Watson, C.J. (1999) "Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3", Genes Dev. 13, 2604-2616.
39. Sano, S., Takahama, Y., Sugawara, T., Kosaka, H., Itami, S., Yoshikawa, K., Miyazaki, J., van Ewijk, W. and Takeda, J. (2001) "Stat3 in thymic epithelial cells is essential for postnatal maintenance of thymic architecture and thymocyte survival", Immunity 15, 261-273.
40. McLemore, M.L., Grewal, S., Liu, F., Archambault, A., Poursine-Laurent, J., Haug, J. and Link, D.C. (2001) "STAT-3 activation is required for normal G-CSF-dependent proliferation and granulocytic differentiation", Immunity 14, 193-204.
41. Lee, C.K., Raz, R., Gimeno, R., Gertner, R., Wistinghausen, B., Takeshita, K., DePinho, R.A. and Levy, D.E. (2002) "STAT3 is a negative regulator of granulopoiesis but is not required for G-CSF-dependent differentiation", Immunity 17, 63-72.
42. Garcia, R. and Jove, R. (1998) "Activation of STAT transcription factors in oncogenic tyrosine kinase signaling", J. Biomed. Sci. 5, 79-85.
43. Yu, C.L., Meyer, D.J., Campbell, G.S., Larner, A.C., Carter-Su, C., Schwartz, J. and Jove, R. (1995) "Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein", Science 269, 81-83.
44. Turkson, J., Bowman, T., Garcia, R., Caldenhoven, E., De Groot, R.P. and Jove, R. (1998) "Stat3 activation by Src induces specific gene regulation and is required for cell transformation", Mol. Cell Biol. 18, 2545-2552.
45. Bromberg, J.F., Horvath, C.M., Besser, D., Lathem, W.W. and Darnell, J.E., Jr (1998) "Stat3 activation is required for cellular transformation by v-src", Mol. Cell Biol. 18, 2553-2558.
46. Bromberg, J.F. and Darnell, J.E., Jr. (1999) "Potential roles of Stat1 and Stat3 in cellular transformation", Cold Spring Harbor Symp. Quant. Biol. 64, 425-428.
47. Benekli, M., Xia, Z., Donohue, K.A., Ford, L.A., Pixley, L.A., Baer, M.R., Baumann, H. and Wetzler, M. (2002) "Constitutive activity of signal transducer and activator of transcription 3 protein in acute myeloid leukemia blasts is associated with short disease-free survival", Blood 99, 252-257.
48. Watson, C.J. and Miller, W.R. (1995) "Elevated levels of members of the STAT family of transcription factors in breast carcinoma nuclear extracts", Br. J. Cancer 71, 840-844.
49. Garcia, R., Yu, C.L., Hudnall, A., Catlett, R., Nelson, K.L., Smithgall, T., Fujita, D.J., Ethier, S.P. and Jove, R. (1997) "Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells", Cell Growth Differ. 8, 1267-1276.
50. Sartor, C.I., Dziubinski, M.L., Yu, C.L., Jove, R. and Ethier, S.P. (1997) "Role of epidermal growth factor receptor and STAT-3 activation in autonomous proliferation of SUM-102PT human breast cancer cells", Cancer Res. 57, 978-987.
51. Mora, L.B., Buettner, R., Seigne, J., Diaz, J., Ahmad, N., Garcia, R., Bowman, T., Falcone, R., Fairclough, R., Cantor, A., Muro-Cacho, C., Livingston, S., Karras, J., Pow-Sang, J. and Jove, R. (2002) "Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells", Cancer Res. 62, 6659-6666.
52. Dalton, W.S. and Jove, R. (1999) "Drug resistance in multiple myeloma: approaches to circumvention", Semin. Oncol. 26, 23-27.
53. Grandis, J.R., Drenning, S.D., Chakraborty, A., Zhou, M.Y., Zeng, Q., Pitt, A.S. and Tweardy, D.J. (1998) "Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor-mediated cell growth in vitro", J. Clin. Investig. 102, 1385-1392.
54. Grandis, J.R. and Tweardy, D.J. (1993) "TGF-alpha and EGFR in head and neck cancer", J. Cell. Biochem.(Suppl. 17F), 188-191.
55. Grandis, J.R., Perez-Perez, G.I., Yu, V.L., Johnson, J.T. and Blaser, M.J. (1997) "Lack of serologic evidence for Helicobacter pylori infection in head and neck cancer", Head Neck 19, 216-218.
56. Grandis, J.R., Drenning, S.D., Zeng, Q., Watkins, S.C., Melhem, M.F., Endo, S., Johnson, D.E., Huang, L., He, Y. and Kim, J.D. (2000) "Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo", Proc. Natl Acad. Sci. USA 97, 4227-4232.
57. Schaefer, T.S., Sanders, L.K. and Nathans, D. (1995) "Cooperative transcriptional activity of Jun and Stat3 beta, a short form of Stat3", Proc. Natl Acad. Sci. USA 92, 9097-9101.
58. Caldenhoven, E., van Dijk, T.B., Solari, R., Armstrong, J., Raaijmakers, J.A., Lammers, J.W., Koenderman, L. and de Groot, R.P. (1996) "STAT3beta, a splice variant of transcription factor STAT3, is a dominant negative regulator of transcription", J. Biol. Chem. 271, 13221-13227.
59. Chakraborty, A., White, S.M., Schaefer, T.S., Ball, E.D., Dyer, K.F. and Tweardy, D.J. (1996) "Granulocyte colony-stimulating factor activation of Stat3 alpha and Stat3 beta in immature normal and leukemic human myeloid cells", Blood 88, 2442-2449.
60. Shao, H., Quintero, A.J. and Tweardy, D.J. (2001) "Identification and characterization of cis elements in the STAT3 gene regulating STAT3 alpha and STAT3 beta messenger RNA splicing", Blood 98, 3853-3856.
61. Park, O.K., Schaefer, L.K., Wang, W. and Schaefer, T.S. (2000) "Dimer stability as a determinant of differential DNA binding activity of Stat3 isoforms", J. Biol. Chem. 275, 32244-32249.
62. Minami, M., Inoue, M., Wei, S., Takeda, K., Matsumoto, M., Kishimoto, T. and Akira, S. (1996) "STAT3 activation is a critical step in gp 130-mediated terminal differentiation and growth arrest of a myeloid cell line", Proc. Natl Acad. Sci. USA 93, 3963-3966.
63. Kawasaki, A., Matsumura, I., Kataoka, Y., Takigawa, E., Nakajima, K. and Kanakura, Y. (2003) "Opposing effects of PML and PML/RAR {alpha} on STAT3 activity", Blood, in press.
64. Xiao, H., Chung, J., Kao, H.Y. and Yang, Y.C. (2003) "TIP60 is a co-repressor for STAT3", J. Biol. Chem. 278, 11197-11204.
65. Giraud, S., Bienvenu, F., Avril, S., Gascan, H., Heery, D.M. and Coqueret, O. (2002) "Functional interaction of STAT3 transcription factor with the coactivator NcoA/SRC1a", J. Biol. Chem. 277, 8004-8011.
66. Altucci, L., Rossin, A., Raffelsberger, W., Reitmair, A., Chomienne, C. and Gronemeyer, H. (2001) "Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL", Nat. Med. 7, 680-686.